CDTX vs CHTR · rev $1.3M vs P/E 11, rev $55.09B
Cidara Therapeutics Inc (CDTX) versus Charter Communications Inc (CHTR) — a side-by-side from cached financials, not a winner call.
Cidara Therapeutics Inc (CDTX) is a biotechnology company listed on US.
Charter Communications Inc (CHTR) is a telecom services company listed on US.
Latest reported CDTX revenue for 2024-12-31 was $1.3M. Net income was -$169.8M. Revenue was down 94.5% from 2023-12-31 to 2024-12-31. CDTX currently screens at market cap $6.96B.
Latest reported CHTR revenue for 2024-12-31 was $55.09B. Net income was $5.85B. Revenue was up 0.9% from 2023-12-31 to 2024-12-31. CHTR currently screens at market cap $56.24B and trailing P/E 11.5.
CDTX currently screens at market cap $6.96B. CHTR currently screens at market cap $56.24B and trailing P/E 11.5.
Not investment advice. Open the CDTX and CHTR stock pages for the full models.
Not investment advice.